METHOD FOR PRODUCING RETINAL TISSUE
    2.
    发明申请

    公开(公告)号:US20190127690A1

    公开(公告)日:2019-05-02

    申请号:US16095339

    申请日:2017-04-21

    摘要: The present invention provides a method for producing a retinal cell or a retinal tissue, including the following steps (1)-(3): (1) a first step of culturing pluripotent stem cells in the absence of feeder cells in a medium containing 1) a TGFβ family signal transduction pathway inhibiting substance and/or a Sonic hedgehog signal transduction pathway activating substance, and 2) a factor for maintaining undifferentiated state, (2) a second step of culturing the cells obtained in the first step in suspension in a medium containing a Wnt signal transduction pathway inhibiting substance to form a cell aggregate, and (3) a third step of culturing the aggregate obtained in the second step in suspension in the presence or absence of a Wnt signal transduction pathway inhibiting substance in a medium containing a BMP signal transduction pathway activating substance to obtain an aggregate containing a retinal cell or a retinal tissue.

    METHOD FOR MANUFACTURING CILIARY MARGINAL ZONE-LIKE STRUCTURE

    公开(公告)号:US20190169570A1

    公开(公告)日:2019-06-06

    申请号:US16267948

    申请日:2019-02-05

    摘要: The present invention provides a method for producing a cell aggregate containing a ciliary marginal zone-like structure, including a step of culturing a cell aggregate containing a retinal tissue in which Chx10 positive cells are present in a proportion of 20% or more and 100% or less of the tissue in a serum-free medium or serum-containing medium each containing a substance acting on the Wnt signal pathway and a substance inhibiting the FGF signal pathway for only a period before the appearance of a RPE65 gene expressing cell, followed by culturing the “cell aggregate in which a RPE65 gene-expressing cell does not appear” thus obtained in a serum-free medium or serum-containing medium each free of a substance acting on the Wnt signal pathway and so on. According to the production method of the present invention, a ciliary marginal zone-like structure can be produced with high efficiency.

    METHOD FOR MANUFACTURING CILIARY MARGINAL ZONE-LIKE STRUCTURE
    9.
    发明申请
    METHOD FOR MANUFACTURING CILIARY MARGINAL ZONE-LIKE STRUCTURE 审中-公开
    制造军事区域结构的方法

    公开(公告)号:US20160376554A1

    公开(公告)日:2016-12-29

    申请号:US15103162

    申请日:2014-10-16

    摘要: The present invention provides a method for producing a cell aggregate containing a ciliary marginal zone-like structure, including a step of culturing a cell aggregate containing a retinal tissue in which Chx10 positive cells are present in a proportion of 20% or more and 100% or less of the tissue in a serum-free medium or serum-containing medium each containing a substance acting on the Wnt signal pathway and a substance inhibiting the FGF signal pathway for only a period before the appearance of a RPE65 gene expressing cell, followed by culturing the “cell aggregate in which a RPE65 gene-expressing cell does not appear” thus obtained in a serum-free medium or serum-containing medium each free of a substance acting on the Wnt signal pathway and so on. According to the production method of the present invention, a ciliary marginal zone-like structure can be produced with high efficiency.

    摘要翻译: 本发明提供了一种含有睫状边缘区域结构的细胞聚集体的制造方法,其特征在于,包括培养包含视网膜组织的细胞集合体的步骤,其中Chx10阳性细胞以20%以上且100%以上的比例存在, 或更少的无血清培养基或含血清的培养基中含有作用于Wnt信号通路的物质的组织,以及抑制FGF信号通路的物质仅在RPE65基因表达细胞出现之前的一段时间后, 在不含有作用于Wnt信号通路的物质的无血清培养基或含血清培养基中培养“RPE65基因表达细胞未出现的细胞集合体”等。 根据本发明的制造方法,可以高效率地制造睫状边缘区域状结构体。

    METHOD FOR PRODUCING DOPAMINERGIC NEURON PROGENITOR CELL

    公开(公告)号:US20190112575A1

    公开(公告)日:2019-04-18

    申请号:US16095092

    申请日:2017-04-24

    IPC分类号: C12N5/0793 C12N5/074

    摘要: A cell population comprising Corin- and/or Lrtm1-positive cells was produced by the following steps (1) and (2), from which Corin positive and/or Lrtm1 positive cells are collected using a substance that binds to Corin and/or a substance that binds to Lrtm1, and dopaminergic neuron progenitor cells are produced by performing suspension culture of the Corin positive and/or Lrtm1 positive cells in a culture solution containing one or more nutritional factors: (1) a step of performing adhesion culture of pluripotent stem cells in a medium for maintaining undifferentiated state containing a Sonic hedgehog (SHH) signal stimulant, and an undifferentiated state-maintaining factor in the absence of feeder cells but in the presence of an extracellular matrix, and (2) a step of culturing the cell population obtained in the step (1) in a culture solution containing one or more differentiation-inducing factors.